Literature DB >> 18325439

Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation.

Yoshihide Takahashi1, Mark D O'Neill, Mélèze Hocini, Rémi Dubois, Seiichiro Matsuo, Sébastien Knecht, Srijoy Mahapatra, Kang-Teng Lim, Pierre Jaïs, Anders Jonsson, Frédéric Sacher, Prashanthan Sanders, Thomas Rostock, Pierre Bordachar, Jacques Clémenty, George J Klein, Michel Haïssaguerre.   

Abstract

OBJECTIVES: This study sought to determine the characteristics of atrial electrograms predictive of slowing or termination of atrial fibrillation (AF) during ablation of chronic AF.
BACKGROUND: There is growing recognition of a role for electrogram-based ablation.
METHODS: Forty consecutive patients (34 male, 59 +/- 10 years) undergoing ablation for chronic AF persisting for a median of 12 months (range 1 to 84 months) were included. After pulmonary vein isolation and roof line ablation, electrogram-based ablation was performed in the left atrium and coronary sinus. Targeted electrograms were acquired in a 4-s window and characterized by: 1) percentage of continuous electrical activity; 2) bipolar voltage; 3) dominant frequency; 4) fractionation index; 5) mean absolute value of derivatives of electrograms; 6) local cycle length; and 7) presence of a temporal gradient of activation. Electrogram characteristics at favorable ablation regions, defined as those associated with slowing (a >or=6-ms increase in AF cycle length) or termination of AF were compared with those at unfavorable regions.
RESULTS: The AF was terminated by electrogram-based ablation in 29 patients (73%) after targeting a total of 171 regions. Ablation at 37 (22%) of these regions was followed by AF slowing, and at 29 (17%) by AF termination. The percentage of continuous electrical activity and the presence of a temporal gradient of activation were independent predictors of favorable ablation regions (p = 0.016 and p = 0.038, respectively). Other electrogram characteristics at favorable ablation regions were not significantly different from those at unfavorable ablation regions.
CONCLUSIONS: Catheter ablation at sites displaying a greater percentage of continuous activity or a temporal activation gradient is associated with slowing or termination of chronic AF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325439     DOI: 10.1016/j.jacc.2007.10.056

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  60 in total

1.  A Decade of CFAE Mapping: Still Seeking More Specific Tools to Identify Sources and Substrate of Persistent Atrial Fibrillation.

Authors:  Amir S Jadidi; Thomas Arentz
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

Review 2.  What Is the Appropriate Lesion Set for Ablation in Patients with Persistent Atrial Fibrillation?

Authors:  Jorge Romero; Carola Gianni; Andrea Natale; Luigi Di Biase
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

3.  Substrate modification by adding ablation of localized complex fractionated electrograms after stepwise linear ablation in persistent atrial fibrillation.

Authors:  Shiro Nakahara; Tohru Kamijima; Yuichi Hori; Naofumi Tsukada; Akiko Okano; Kan Takayanagi
Journal:  J Interv Card Electrophysiol       Date:  2013-11-30       Impact factor: 1.900

Review 4.  AF Termination: the Holy Grail of Persistent AF Ablation?

Authors:  Dennis H Lau; Anthony G Brooks; Prashanthan Sanders
Journal:  J Atr Fibrillation       Date:  2010-06-01

Review 5.  Is Isolation of Arrhythmogenic Pulmonary Veins Sufficient for the Long-term Efficacy of Atrial Fibrillation Ablation?

Authors:  Sanjay Dixit
Journal:  J Atr Fibrillation       Date:  2010-06-01

Review 6.  Ablation of Longstanding Persistent Atrial Fibrillation.

Authors:  Edward J Ciaccio
Journal:  J Atr Fibrillation       Date:  2010-10-22

7.  AF Termination: the Holy Grail of Persistent AF Ablation?

Authors:  Dennis H Lau; Anthony G Brooks; Prashanthan Sanders
Journal:  J Atr Fibrillation       Date:  2008-05-16

8.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

9.  Catheter ablation of persistent atrial fibrillation: The importance of substrate modification.

Authors:  Konstantinos P Letsas; Michael Efremidis; Nikolaos P Sgouros; Konstantinos Vlachos; Dimitrios Asvestas; Antonios Sideris
Journal:  World J Cardiol       Date:  2015-03-26

10.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial.

Authors:  Sanjiv M Narayan; David E Krummen; Kalyanam Shivkumar; Paul Clopton; Wouter-Jan Rappel; John M Miller
Journal:  J Am Coll Cardiol       Date:  2012-07-18       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.